Oncternal Therapeutics (ONCT) News Today $4.16 +0.09 (+2.21%) (As of 09/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period September 9 at 6:37 AM | americanbankingnews.comOncternal Therapeutics (NASDAQ:ONCT) Now Covered by Analysts at StockNews.comSeptember 1, 2024 | americanbankingnews.comOncternal Therapeutics (NASDAQ:ONCT) Receives New Coverage from Analysts at StockNews.comAugust 22, 2024 | uk.finance.yahoo.comContraVir Pharmaceuticals, Inc. (CTRVP)August 11, 2024 | finance.yahoo.comOncternal Therapeutics Second Quarter 2024 Earnings: Beats ExpectationsAugust 9, 2024 | markets.businessinsider.comOncternal Therapeutics earnings preview: what to expectAugust 8, 2024 | investorplace.comONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024August 8, 2024 | globenewswire.comOncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial ResultsAugust 1, 2024 | globenewswire.comOncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial ResultsJuly 11, 2024 | globenewswire.comOncternal Therapeutics to Present in JonesTrading Healthcare SummitMay 30, 2024 | globenewswire.comOncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate CancerMay 11, 2024 | msn.comOncternal Therapeutics, Inc. (NASDAQ:ONCT) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comQ1 2024 Oncternal Therapeutics Inc Earnings CallMay 9, 2024 | msn.comONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q1 2024May 9, 2024 | sfgate.comOncternal Therapeutics: Q1 Earnings SnapshotMay 9, 2024 | globenewswire.comOncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial ResultsMay 8, 2024 | markets.businessinsider.comOncternal Therapeutics earnings: here's what Wall Street expectsMay 7, 2024 | markets.businessinsider.comOppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)May 2, 2024 | globenewswire.comOncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial ResultsMay 1, 2024 | globenewswire.comOncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)April 23, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Addus Homecare (ADUS)April 19, 2024 | uk.finance.yahoo.comEwing Sarcoma Drug Pipeline Market Research 2024: Insights About 25+ Companies and 25+ Pipeline DrugsApril 18, 2024 | globenewswire.comOncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate CancerApril 17, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Hold Rating on Oncternal Therapeutics (ONCT)April 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Oncternal Therapeutics with Adjusted Price Target Amid Positive Financials and Upcoming CatalystsApril 14, 2024 | insidermonkey.com5 Buy-Rated Stocks with Latest Insider PurchasesApril 11, 2024 | finance.yahoo.comAIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USAApril 11, 2024 | insidertrades.comOncternal Therapeutics, Inc. (NASDAQ:ONCT) Director Acquires $27,650.56 in StockApril 2, 2024 | insidertrades.comOncternal Therapeutics, Inc. (NASDAQ:ONCT) Director Robert James Wills Purchases 6,914 SharesMarch 15, 2024 | globenewswire.comOncternal Participating in Virtual Fireside Chat with Key Opinion Leader on Treatment Landscape & New Treatment Options for Prostate CancerMarch 13, 2024 | markets.businessinsider.comNorthland Securities Keeps Their Buy Rating on Heron Therapeutics (HRTX)March 10, 2024 | finance.yahoo.comOncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In LineMarch 8, 2024 | finance.yahoo.comQ4 2023 Oncternal Therapeutics Inc Earnings CallMarch 8, 2024 | msn.comOncternal Therapeutics, Inc. (NASDAQ:ONCT) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | benzinga.comOncternal Therapeutics's Earnings: A PreviewMarch 7, 2024 | msn.comONCT Stock Earnings: Oncternal Therapeutics Misses EPS, Beats Revenue for Q4 2023March 7, 2024 | benzinga.comRecap: Oncternal Therapeutics Q4 EarningsMarch 7, 2024 | washingtonpost.comOncternal Therapeutics: Q4 Earnings SnapshotMarch 7, 2024 | globenewswire.comOncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 6, 2024 | markets.businessinsider.comOncternal Therapeutics earnings: here's what to expectFebruary 29, 2024 | globenewswire.comOncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial ResultsFebruary 25, 2024 | finance.yahoo.comOncternal Therapeutics (NASDAQ:ONCT) Will Have To Spend Its Cash WiselyFebruary 6, 2024 | finance.yahoo.comOncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences ConferenceFebruary 3, 2024 | morningstar.comOncternal Therapeutics Inc ONCTJanuary 30, 2024 | ca.finance.yahoo.comONCT Jul 2024 7.500 callJanuary 30, 2024 | ca.finance.yahoo.comONCT Apr 2024 2.500 callJanuary 8, 2024 | finance.yahoo.comOncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate CancerJanuary 8, 2024 | marketbeat.comTrading was temporarily halted for "ONCT" at 07:01 PM with a stated reason of "News pending."January 4, 2024 | msn.comOncternal Therapeutics announces a reverse stock splitJanuary 4, 2024 | finance.yahoo.comOncternal Therapeutics Announces Reverse Stock SplitDecember 26, 2023 | nasdaq.comOncternal Therapeutics Updates Early Disease Response Data For ONCT-808; Shares Fall Get Oncternal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter. Email Address ONE AI Stock is All You Need... (Ad)If you want the potential for huge gains with AI stocks... You need to ignore 99% of the stock market. Click here for the ticker >>> ONCT Media Mentions By Week ONCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCT News Sentiment▼0.000.44▲Average Medical News Sentiment ONCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCT Articles This Week▼11▲ONCT Articles Average Week Get Oncternal Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRPH News CALC News ZIVO News LEXX News ANEB News VTVT News RLYB News DRRX News AADI News KZR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCT) was last updated on 9/11/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Coin Could 10x FASTER Than BitcoinA shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | SponsoredFREE TRAINING TODAY ➡️ How to profit from 2024 electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredHow to grow a small trading account into a $100k? Why is Warren Buffett dumping stocks? Billionaires like Warren Buffett, Tim Cook, and Jeff Bezos are offloa...Timothy Sykes | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThis technology could swing the electionHidden in America's forgotten towns, a groundbreaking energy discovery is taking shape. And it's happening rig...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncternal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncternal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONCT Stock Alerts